Early Statin Use May Delay Dementia in Diabetes Patients, Study Finds

Danish diabetes cohort shows statin timing linked to dementia risk reduction

A Danish study tracking 132,585 adults with type 2 diabetes from 2006 to 2019 found early statin initiation (<1 year after diagnosis) reduced dementia risk by 15% at 10-year follow-up compared to no statins. Late initiation (1-5 years post-diagnosis) lowered risk by 10%. Absolute dementia risk at 10 years was 3.9% for no statins, 3.5% for late statins, and 3.3% for early statins. The research, published in *The Lancet Regional Health*, confirms statins prescribed after diabetes diagnosis correlate with lower dementia risk in this specific cohort. However, the observational design cannot prove causation between statin use and dementia reduction. This finding suggests diabetes patients could benefit from earlier statin therapy to support cognitive health, though the effect size is modest and applies only to this Danish population over a decade. The source's detail on timing and absolute risk figures is precise but the study's limitations mean broader application requires further research.

*Source is brief and the detail sits with them.*

Source: ScienceAlert